MAPT and tauopathy: The recent discovery that different tau strains are sufficient to induce diverse neuropathological outcomes in mouse models and the atomistic description of tau fibril polymorphs (structural variants) associated with unique tauopathies suggests that defining the relationship between tau strains and clinical syndromes will let us diagnose and thus treat tauopathies more effectively.